Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling.

Colomb F, Giron LB, Premeaux TA, Mitchell BI, Niki T, Papasavvas E, Montaner LJ, Ndhlovu LC, Abdel-Mohsen M.

Front Immunol. 2019 Feb 20;10:267. doi: 10.3389/fimmu.2019.00267. eCollection 2019.

2.

Breaking the Glyco-Code of HIV Persistence and Immunopathogenesis.

Colomb F, Giron LB, Trbojevic-Akmacic I, Lauc G, Abdel-Mohsen M.

Curr HIV/AIDS Rep. 2019 Feb 1. doi: 10.1007/s11904-019-00433-w. [Epub ahead of print] Review.

PMID:
30707400
3.

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.

Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genescà M, Castellví J, Wu G, Del Rio Estrada PM, González-Navarro M, Lynn K, King CT, Vemula S, Cox K, Wan Y, Li Q, Mounzer K, Kostman J, Frank I, Paiardini M, Hazuda D, Reyes-Terán G, Richman D, Howell B, Tebas P, Martinez-Picado J, Planelles V, Buzon MJ, Betts MR, Montaner LJ.

Sci Transl Med. 2018 Apr 18;10(437). pii: eaar6759. doi: 10.1126/scitranslmed.aar6759.

4.

Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy.

Vadrevu SK, Trbojevic-Akmacic I, Kossenkov AV, Colomb F, Giron LB, Anzurez A, Lynn K, Mounzer K, Landay AL, Kaplan RC, Papasavvas E, Montaner LJ, Lauc G, Abdel-Mohsen M.

J Leukoc Biol. 2018 Sep;104(3):461-471. doi: 10.1002/JLB.3HI1217-500R. Epub 2018 Apr 6.

PMID:
29633346
5.

Absence of neurocognitive disadvantage associated with paediatric HIV subtype A infection in children on antiretroviral therapy.

Bangirana P, Ruel TD, Boivin MJ, Pillai SK, Giron LB, Sikorskii A, Banik A, Achan J.

J Int AIDS Soc. 2017 Oct;20(2). doi: 10.1002/jia2.25015.

6.

Thalidomide is Associated With Increased T Cell Activation and Inflammation in Antiretroviral-naive HIV-infected Individuals in a Randomised Clinical Trial of Efficacy and Safety.

Vergara TRC, Samer S, Santos-Oliveira JR, Giron LB, Arif MS, Silva-Freitas ML, Cherman LA, Treitsman MS, Chebabo A, Sucupira MCA, Da-Cruz AM, Diaz RS; SPARC Working Group.

EBioMedicine. 2017 Sep;23:59-67. doi: 10.1016/j.ebiom.2017.08.007. Epub 2017 Aug 12.

7.

High prevalence and incidence of HIV-1 in a counseling and testing center in the city of Itajaí, Brazil.

Grinberg G, Giron LB, Knoll RK, Galinskas J, Camargo M, Arif MS, Samer S, Janini LM, Sucupira MC, Diaz RS.

Braz J Infect Dis. 2015 Nov-Dec;19(6):631-5. doi: 10.1016/j.bjid.2015.08.001. Epub 2015 Sep 9.

8.

Human gammaherpesviruses viraemia in HIV infected patients.

Ferraz da Silva AP, Giron LB, Ramos da Silva S, Naime Barbosa A, Almeida RA, Elgui de Oliveira D.

J Clin Pathol. 2015 Sep;68(9):726-32. doi: 10.1136/jclinpath-2014-202840. Epub 2015 May 15.

PMID:
25979989
9.

Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus.

Giron LB, Ramos da Silva S, Barbosa AN, Monteiro de Barros Almeida RA, Rosário de Souza Ld, Elgui de Oliveira D.

J Med Virol. 2013 Dec;85(12):2110-8. doi: 10.1002/jmv.23722. Epub 2013 Sep 6.

PMID:
24014234
10.

Comparative effectiveness of dried-plasma hepatitis B virus viral load (VL) testing in three different VL commercial platforms using ViveST for sample collection.

Zanoni M, Giron LB, Vilhena C, Sucupira MC, Lloyd RM Jr, Diaz RS.

J Clin Microbiol. 2012 Jan;50(1):145-7. doi: 10.1128/JCM.01016-11. Epub 2011 Oct 19.

Supplemental Content

Loading ...
Support Center